The leading domestic endoscopy company Kaisei Medical said that Europe as a whole (including non-EU countries such as the United Kingdom) accounts for about 20% of overseas revenue, accounting for about 10% of the company's revenue. The international political game is complicated. Currently, it is still just an investigation intention. Even if confirmed, the investigation cycle, policy and regulation cycle is very long. It is still far from clear whether tariffs will be implemented in the future or in what form. It is unlikely to have a substantial impact in the short term and wait for development. According to Kaizhi Medical, even if there is a policy in the future, domestic companies will respond in various ways such as joint ventures, factories, and OEMs. (Exciting)
开立医疗谈“欧盟启动对华医疗器械采购市场准入调查”：静待发展
Open Medical Talk “EU Launches Medical Device Procurement Market Entry Survey to China”: Waiting for Development
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.